$24.05
-0.51-2.08%
Ult. Agg.: Oct 23, 4:00 PM
Beam Therapeutics (BEAM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.11 | $-0.98 | $-1.12 | $-1.01 |
| Actual | $-1.18 | $-0.91 | $-0.10 | $-1.10 |
| Surprise | -6.31% | +7.14% | +91.1% | -8.91% |
| Revenue | ||||
| Estimate | $18.9M | $13.9M | $13.6M | $12.8M |
| Actual | $490000 | $31.7M | $114.1M | $9.7M |
| Surprise | -97.4% | +127.7% | +736.1% | -24.4% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.17 | $-1.20 | $-1.31 | $-1.37 |
| Revenue | ||||
| Consensus | $10.2M | $11.5M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $-1.18 | $-1.11 | -6.31 % |
| Q1 | May 7, 2026 | $-0.91 | $-0.98 | 7.14 % |
| Q4 | Feb 24, 2026 | $-0.10 | $-1.12 | 91.1 % |
| Q3 | Nov 4, 2025 | $-1.10 | $-1.01 | -8.91 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $490.00K | $18.92M | -97.4 % |
| Q1 | May 7, 2026 | $31.74M | $13.94M | 127.7 % |
| Q4 | Feb 24, 2026 | $114.11M | $13.65M | 736.1 % |
| Q3 | Nov 4, 2025 | $9.70M | $12.83M | -24.4 % |